Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.2% |
| 2 | Healthcare | 7.6% |
| 3 | Financials | 5.15% |
| 4 | Consumer Discretionary | 5.03% |
| 5 | Industrials | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRFT
3926
DELISTED
Perficient Inc
PRFT
| $1.24M | ﹤0.01% |
21,489
+16,147
| +302% | +$1.11M |
|
3927
Standard BioTools
LAB
$321M
| $1.24M | ﹤0.01% |
428,601
-157,666
| -27% | -$412K |
|
3928
MGP Ingredients
MGPI
$366M
| $1.24M | ﹤0.01% |
+11,760
| New | +$1.33M |
|
3929
CALL
Smith & Nephew
SNN
$12.8B
| $1.24M | ﹤0.01% |
50,000
+20,000
| +67% | +$562K |
|
3930
CALL
Uber
UBER
$147B
| $1.24M | ﹤0.01% |
26,900
-26,400
| -50% | -$1.21M |
|
3931
CALL
Zillow
Z
$8.3B
| $1.24M | ﹤0.01% |
26,800
+12,000
| +81% | +$617K |
|
3932
Capital City Bank Group
CCBG
$902M
| $1.24M | ﹤0.01% |
41,467
-4,639
| -10% | -$144K |
|
3933
Rentokil
RTO
$12.6B
| $1.23M | ﹤0.01% |
33,318
-17,620
| -35% | -$673K |
|
3934
Schwab U.S Small- Cap ETF
SCHA
$23.2B
| $1.23M | ﹤0.01% |
+59,512
| New | +$1.31M |
|
3935
LivePerson
LPSN
$27M
| $1.23M | ﹤0.01% |
21,087
-124,112
| -85% | -$8.17M |
|
3936
Moelis & Co
MC
$5.09B
| $1.23M | ﹤0.01% |
+27,186
| New | +$1.28M |
|
3937
PUT
Motorola Solutions
MSI
$73.5B
| $1.23M | ﹤0.01% |
4,500
+3,600
| +400% | +$1.03M |
|
3938
Adicet Bio
ACET
$86.1M
| $1.22M | ﹤0.01% |
55,868
+7,138
| +15% | +$252K |
|
3939
Pennant Group
PNTG
$1.34B
| $1.22M | ﹤0.01% |
109,704
-298,678
| -73% | -$3.46M |
|
3940
Dream Finders Homes
DFH
$1.3B
| $1.22M | ﹤0.01% |
+54,905
| New | +$1.43M |
|
3941
Stepan Co
SCL
$1.45B
| $1.22M | ﹤0.01% |
16,265
-9,941
| -38% | -$869K |
|
|
VERV
3942
DELISTED
Verve Therapeutics
VERV
| $1.22M | ﹤0.01% |
+91,948
| New | +$1.48M |
|
3943
LeMaitre Vascular
LMAT
$2.42B
| $1.22M | ﹤0.01% |
22,327
-73,591
| -77% | -$4.36M |
|
|
NOTV
3944
DELISTED
Inotiv
NOTV
| $1.21M | ﹤0.01% |
393,552
-430,596
| -52% | -$1.97M |
|
|
CMBM
3945
DELISTED
Cambium Networks
CMBM
| $1.21M | ﹤0.01% |
165,324
-14,598
| -8% | -$158K |
|
3946
Advanced Drainage Systems
WMS
$11.5B
| $1.21M | ﹤0.01% |
10,641
+5,117
| +93% | +$625K |
|
3947
Riley Exploration Permian
REPX
$730M
| $1.21M | ﹤0.01% |
38,034
+3,841
| +11% | +$131K |
|
|
BRT
3948
BRT Apartments
BRT
$268M
| $1.21M | ﹤0.01% |
69,951
+5,020
| +8% | +$94.9K |
|
3949
PUT
GSK
GSK
$103B
| $1.21M | ﹤0.01% |
+33,300
| New | +$1.18M |
|
3950
Cogent Biosciences
COGT
$7.32B
| $1.21M | ﹤0.01% |
123,689
-496,327
| -80% | -$5.89M |
|
Similar funds
Millennium Management's Q3 2023 Portfolio in Review
As of Q3 2023, Millennium Management held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Millennium Management's Q3 2023 filing shows 836 new, 2,327 increased, 2,312 reduced and 834 closed positions. Its largest new stake was Mobileye: 2,953,164 shares worth $123M. The largest sale was iShares Core S&P 500 ETF, an estimated $689M.
By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Financials.
- Millennium Management's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Millennium Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Millennium Management fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Millennium Management's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Millennium Management opened 836 new positions and closed 834 in Q3 2023.
- Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.